close
Add to watchlist
Neuralstem Inc (CUR)
Neuralstem, Inc., a biotechnology company, focuses on developing and commercializing human neural stem cell technology in the field of regenerative medicine primarily in the United States. The company uses its human neural stem cell technology to create biotherapeutic products for the treatment of central nervous system diseases and various neurodegenerative conditions, and for the regenerative repair of acute diseases. Its proprietary technology is also used in small-molecule drug discovery. The company has a research agreement with China Medical University & Hospital of Taiwan to prepare for a human clinical trial using human spinal cord neural stem cells to treat stroke patients. Neuralstem, Inc. was founded in 1996 and is headquartered in Rockville, Maryland.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 1.16 |
| Volume | 50876 |
| Volume Avg | 93936 |
| 52 Week High | 2.12 |
| 52 Week Low | 0.86 |
| PE | N/A |
| PE (group average) | N/A |
| EPS Year | -0.27 |
| EPS change Q/Q | -16.67% |
| EPS change Q/Q Yr ago | -61.11% |
| EPS change Q/Q next Q est | -16.67% |
| EPS change Y/Y | -50% |
| REV change Q/Q | 100% |
| REV change Q/Q Yr ago | 0% |
| EPS next Q est | -0.06 |
| EPS next Y est | -0.27 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |